Active Pharmaceutical Ingredient:

Any substance or combination of substances used in a finished pharmaceutical product (FPP), intended to furnish pharmacological activity or to otherwise have direct effect in the diagnosis, cure, mitigation, treatment or prevention of disease, or to have direct effect in restoring, correcting or modifying physiological functions in human beings.

1. Categories Of Active Pharmaceutical Ingredient:

   Antipyretics Drugs

   Analgesics Drugs

   Antimalarial Drugs

   Antibiotics

   Antiemetics Drugs

   Antifungal Drugs

   Antiallergic Drugs

   Antidiabetic Drugs

   Antidiuretic Drugs

   Cardiology Drugs

   Dermatology Drugs

   Neurologys Drugs

   Nephrology Drugs

   Gastroenterology Drugs

   APIs for obstetrics and gynaecology Drugs

   APIs for Nutraceutical/Food supplements/Vitamins

   Any other API(s) on Request…

   APIs Name	Pharmacopeial Grade	Therapeutic category/Use	CAS Number
   APIs Name	Pharmacopeial Grade	Therapeutic category/Use	CAS Number
   APIs Name	Pharmacopeial Grade	Therapeutic category/Use	CAS Number
   APIs Name	Pharmacopeial Grade	Therapeutic category/Use	CAS Number
   APIs Name	Pharmacopeial Grade	Therapeutic category/Use	CAS Number
   APIs Name	Pharmacopeial Grade	Therapeutic category/Use	CAS Number
   APIs Name	Pharmacopeial Grade	Therapeutic category/Use	CAS Number
   APIs Name	Pharmacopeial Grade	Therapeutic category/Use	CAS Number
   APIs Name	Pharmacopeial Grade	Therapeutic category/Use	CAS Number
   APIs Name	Pharmacopeial Grade	Therapeutic category/Use	CAS Number
   APIs Name	Pharmacopeial Grade	Therapeutic category/Use	CAS Number
   APIs Name	Pharmacopeial Grade	Therapeutic category/Use	CAS Number
   APIs Name	Pharmacopeial Grade	Therapeutic category/Use	CAS Number
   APIs Name	Pharmacopeial Grade	Therapeutic category/Use	CAS Number

   Disclaimer: Products protected under valid patents are not offered or supplied for commercial use. However, the research quantities of such products may be offered for the purpose of regulatory submissions, wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities